These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8048334

  • 21. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB, Haxby JV, Grady CL, Duara R, Schlageter NL, White B, Moore A, Sundaram M, Larson SM, Rapoport SI.
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [Abstract] [Full Text] [Related]

  • 22. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G, Stone-Elander S, Halldin C, Roland PE, Swahn CG, Haaparanta M, Solin O, Lindqvist M, Widén L.
    Acta Radiol Suppl; 1991 Jun; 376():171-2. PubMed ID: 1666769
    [No Abstract] [Full Text] [Related]

  • 23. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P, Dive D, Salmon E, von Frenckel R, Franck G.
    Eur J Nucl Med; 1990 Jun; 16(4-6):267-73. PubMed ID: 2351175
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects.
    Evans AC, Diksic M, Yamamoto YL, Kato A, Dagher A, Redies C, Hakim A.
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):724-38. PubMed ID: 3491827
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis.
    Dalakas MC, Hatazawa J, Brooks RA, Di Chiro G.
    Ann Neurol; 1987 Nov; 22(5):580-6. PubMed ID: 3501273
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Comparative analysis of regional brain blood flow and glucose metabolism in focal cerebrovascular disease measured by dynamic positron emission tomography of fluorine-18-labelled tracers.
    Beil C.
    J Neurol; 1987 Jun; 234(5):315-21. PubMed ID: 3497233
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cerebral glucose metabolic rates after 30 and 45 minute acquisitions: a comparative study.
    Kumar A, Braun A, Schapiro M, Grady C, Carson R, Herscovitch P.
    J Nucl Med; 1992 Dec; 33(12):2103-5. PubMed ID: 1460500
    [Abstract] [Full Text] [Related]

  • 35. [Analysis of regional blood flow, blood volume, oxygen and glucose metabolism in heterogeneous parts of untreated high grade gliomas using positron emission tomography (PET)].
    Sasajima T, Mineura K, Kowada M, Shishido F, Uemura K.
    No Shinkei Geka; 1989 Nov; 17(11):1005-13. PubMed ID: 2594150
    [Abstract] [Full Text] [Related]

  • 36. Regional glucose metabolic rates in the human brain: a PET study.
    Gulyás B, Trón L, Balkay L, Emri M, Molnár T, Tóth G, Marian T.
    Acta Biol Hung; 1996 Nov; 47(1-4):157-72. PubMed ID: 9123988
    [Abstract] [Full Text] [Related]

  • 37. Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI-PET scanning.
    Newberg AB, Wang J, Rao H, Swanson RL, Wintering N, Karp JS, Alavi A, Greenberg JH, Detre JA.
    Neuroimage; 2005 Nov 01; 28(2):500-6. PubMed ID: 16084114
    [Abstract] [Full Text] [Related]

  • 38. [Cerebral glucose metabolism in autistic children. Study and positron emission tomography].
    De Volder AG, Bol A, Michel C, Cogneau M, Goffinet AM.
    Acta Neurol Belg; 1988 Nov 01; 88(2):75-90. PubMed ID: 3260437
    [Abstract] [Full Text] [Related]

  • 39. The influence of biological and technical factors on the variability of global and regional brain metabolism of 2-[18F]fluoro-2-deoxy-D-glucose.
    Camargo EE, Szabo Z, Links JM, Sostre S, Dannals RF, Wagner HN.
    J Cereb Blood Flow Metab; 1992 Mar 01; 12(2):281-90. PubMed ID: 1548300
    [Abstract] [Full Text] [Related]

  • 40. Human brain glucose utilization and cognitive function in relation to age.
    Duara R, Grady C, Haxby J, Ingvar D, Sokoloff L, Margolin RA, Manning RG, Cutler NR, Rapoport SI.
    Ann Neurol; 1984 Dec 01; 16(6):703-13. PubMed ID: 6335379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.